Case guide

CPAP and Cancer: Which Facts Need a Check?

A recall risk, a diagnosis and a program’s cancer list each answer a different question. Check the real medical and claim records.

See If You Qualify

Free · No obligation · About 2 minutes

Updated Oct 4, 202612 sources

This may apply to you if

  • Identify the actual Philips model and your dates of use.
  • Bring the diagnosis and treatment records for an individual legal check.
  • Tell the lawyer about any replacement, earlier registration or agreement.

What the public record says

These are cited sources. Their inclusion does not imply that they endorse People’s Justice or reviewed this page.

Grégoire Justeau · Department of Respiratory and Sleep Medicine, Angers University Hospital, France · First-listed author of the original CPAP cancer cohort

Finding: The 4,447-person cohort found no increased overall cancer incidence among Philips users compared with other brands. Its observational design and follow-up cannot exclude every risk or decide an individual cause.

Justeau original CPAP cancer cohort, 2022 (opens in a new tab) · Jul 14, 2022 · Checked Oct 3, 2026

Joy Flowers Conti · United States District Court for the Western District of Pennsylvania · Senior United States District Judge

Finding: The January 16, 2026 opinion grants remand of the Graham case to Kentucky state court. It records past settlements and a January 31, 2025 private injury-settlement registration date; it does not decide personal medical cause or injury compensation.

Graham court opinion, January 16, 2026 (opens in a new tab) · Jan 16, 2026 · Checked Oct 3, 2026

The evidence and its limits

Pays de la Loire Sleep Cohort Study Group; Angers University Hospital, France · European Respiratory Journal · 2022

Cancer risk in adherent users of polyurethane foam-containing CPAP devices for sleep apnoea

Design:
Cohort
Participants:
4,447 patients, including 1,648 Philips and 2,799 other-device users
Finding:
No association with increased overall cancer incidence was found over a median 7.2-year follow-up.
Main limitation
Observational design, possible unmeasured factors and limited ability to detect certain cancers. Two authors disclosed Philips lecture honoraria outside the study. This does not establish individual cause or all-model safety.

Read the source: Cancer risk in adherent users of polyurethane foam-containing CPAP devices for sleep apnoea (opens in a new tab) · Checked Oct 3, 2026

The short answer

Does the recall establish a list of cancers it caused?
FDA describes potential cancer-causing risks from the recalled foam. That is not a diagnosis or proof of one person’s cancer cause. [6]
What does the actual diagnosis need to explain?
Ask which cancer and body site the health records name. A device list cannot diagnose the disease. [12]
What cancer evidence offers a different result?
The French study found no higher overall cancer rate for Philips users. It cannot rule out every risk or decide your own cause. [8]
How is a private program’s cancer list different?
It describes that agreement’s terms, not every medical cause or claim. Ask for the actual program and status. [9]

The process

What happens next

  1. 01

    You answer a few questions

    About two minutes. Nothing is sent until you agree on the last step and press submit.

  2. 02

    A lawyer looks at it

    A lawyer at the firm reads your answers and checks them against the current case criteria.

  3. 03

    The firm decides and gets in touch

    If the firm takes your case, you get the terms in writing to read before you sign. You can always say no.

A recall risk, a diagnosis and a program’s cancer list each answer a different question. Check the real medical and claim records. Do not assume one proves another.

Does the recall establish a list of cancers it caused?

FDA describes potential cancer-causing risks from the recalled foam. That is not a diagnosis or proof of one person’s cancer cause.

The June 2021 recall covered certain Philips devices, not every CPAP machine. FDA says particles or some chemicals may be breathed in or swallowed if foam breaks down. Those are possible risks. Keep them distinct from the actual diagnosis and records of the device you used.

What does the actual diagnosis need to explain?

Ask which cancer and body site the health records name. A device list cannot diagnose the disease.

NCI describes cancer behind the nose as a distinct disease assessed through medical history, examination and tests. Its guide notes causes and risk factors outside this recall, not a CPAP-cause finding. Ask your care team about your own cancer findings instead of using a legal page to select a diagnosis.

What cancer evidence offers a different result?

The French study found no higher overall cancer rate for Philips users. It cannot rule out every risk or decide your own cause.

The 4,447-person study compared 1,648 Philips and 2,799 other-device users over a median 7.2-year follow-up. This was observational, not a device-assignment trial. Its limitations and two authors’ disclosed Philips lecture fees outside the study belong with the finding; it does not certify all models as safe.

How is a private program’s cancer list different?

It describes that agreement’s terms, not every medical cause or claim. Ask for the actual program and status.

The January 16, 2026 Graham ruling records a private injury deal. It defines certain conditions and notes a January 31, 2025 sign-up date. The listed cancers do not prove every patient’s acceptance. That old program date is not every person’s civil filing limit.

What should I ask before agreeing to help?

Ask which claim and law fit and what action comes next. Get legal fees and case-cost terms in writing.

Disclose earlier cases, releases and program papers and ask for a personal time-limit review. The fee agreement should explain the recovery share, deductions and any costs after a loss under the actual applicable terms. Nothing in a comparison of cancer categories confirms firm acceptance or a recovery for your family.

Find out where you stand.

The review is free and private. Asking for it doesn’t commit you to anything.

Register your interest

Sources

  1. HHS: Your Medical RecordsHHS: Your Medical Records · regulator
  2. Federal courts: civil casesFederal courts: civil cases · court
  3. ABA: fees paid from a successful claimABA: fees paid from a successful claim
  4. SDNY: filing time limitsSDNY: filing time limits · court
  5. ABA Model Rule 1.5: feesABA Model Rule 1.5: fees
  6. FDA recalled Philips device patient guidanceFDA recalled Philips device patient guidance · regulator
  7. FDA foam testing summaryFDA foam testing summary · regulator
  8. Justeau original CPAP cancer cohort, 2022Justeau original CPAP cancer cohort, 2022 · study
  9. Graham court opinion, January 16, 2026Graham court opinion, January 16, 2026 · court
  10. Philips announced (Apr 29, 2024) a $1.1 billion total resolution of US Respironics personal-injury and medical-monitoring litigation; the official court settlement site confirms $1.075 billion for personal-injury claims in MDL 3014 and Massachusetts state court (~58,000 registrants; injuries diagnosed by Apr 29, 2024 qualify). A January 16, 2026 court opinion says payments were anticipated in early 2026; no admission of liability.respironicspisettlement.com · Apr 29, 2024
  11. Philips announced resolution of the US economic-loss class litigation in MDL 3014 (Sept 7, 2023 press release): predefined cash awards by device type, extended warranties, and a return bonus; Philips' release cites a EUR 575 million Q1 2023 provision and explicitly excludes personal injury and medical monitoring claims. The commonly cited $479 million settlement figure is from secondary press coverage (Drugwatch), not Philips' own release — flagged accordingly.usa.philips.com · Sep 7, 2023
  12. NCI PDQ patient nasopharyngeal cancer, updated May12,2025

Checked against 10 primary sources by People's Justice editors · Updated

How we make money

People's Justice research team · Updated Oct 4, 2026